HEALTH RESEARCH IN AFRICA

About the Journal

ISSN: 3006-4090 EISSN: 3006-4104

Health Research in Africa (HRA) is an open access, peer reviewed medical journal that is affiliated to Health Sciences and Disease. HRA values high quality research with impact on clinical care in order to improve human health in Africa. HRA covers all aspects of medicine, pharmacy, biomedical and health sciences, including public health and societal issues. Like HSD, it is an “online first” publication, which means that all the publications articles appear on the website before being included in the print journal. The papers are published in full on the website, with open access. Acceptance of manuscripts is based on the originality, the quality of the work and validity of the evidence, the clarity of presentation, and the relevance to our readership. Publications are expected to be concise, well organized and clearly written. Authors submit a manuscript with the understanding that the manuscript (or its essential substance) has not been published other than as an abstract in any language or format and is not currently submitted elsewhere for print or electronic publication. HRA is published by Afrimvoe Medical Services, Yaounde (Cameroon).

Current Issue

Vol. 2 No. 5 (2024): Health Research in Africa

View All Issues

EDITORIAL POLICIES, ETHICS AND PEER REVIEWING

Ethics

HRA’s Publications Policy Committee follows the recommendations of the International Committee of Medical Journal Editors (ICMJE), the World Association of Medical Editors (WAME), and the Committee on Publication Ethics (COPE) for guidance on policies and procedures related to publication ethics. The policies for HRA have been adapted from those three advisory bodies and, where necessary, modified and tailored to meet the specific content, audiences, and aims of HRA.
Review process

Research manuscripts are initially checked by the editor in chief or section editor for identification of gross deficiencies. At this stage, the proposal may be rejected. After this initial screening, articles are sent to one or two-reviewers whose names are hidden from the author and whose review is guided by a checklist (single anonymized review). The review summary is signed by the reviewer and is not posted with article. The review process may take days to weeks to reach a final decision that is the responsibility of the editor in chief. The duration from submission to publication may take one to six months (average: 6 months). So, the authors should avoid contacting the editorial office less than 6 weeks after the initial submission.

Plagiarism, Scientific Misconduct
Manuscripts proven of plagiarism will be returned to the authors without peer review. The editors reserve the right to request that the authors provide additional data collected during their investigations. The editors also reserve the right to send a copy of the manuscript and data in question to the author’s dean, university, or supervisor or, in the case of an investigation being funded by an agency, to that funding agency for appreciation.
Conflict of Interest
At the time of submission, authors are asked to disclose whether they have any financial interests or connections, direct or indirect, or other situations that may influence directly or indirectly the work submitted for consideration.
Human and Animal Studies
Manuscripts reporting results of prospective or retrospective studies involving human subjects must document that appropriate institutional review board (IRB) approval and informed consent were obtained (or waived by the IRB) after the nature of the procedure(s) had been fully explained.
Authorship
To be listed as an author, an individual must have made substantial contributions to all three categories established by the International Committee of Medical Journal Editors (ICMJE) : (a) “conception and design, or acquisition of data, or analysis and interpretation of data,” (b) “drafting the article or revising it critically for important intellectual content,” and (c) “final approval of the version to be published.” Individuals who have not made substantial contributions in all three categories but who have made substantial contributions either to some of them or in other areas should be listed in acknowledgments.
Please limit the number of authors to ten when this is feasible.

Content licensing - Open access compliance - Copyright
Since its creation, articles published in HRA are Open Access and distributed under the terms of the Creative Commons Non-Commercial No-Derivatives License (CC BY-NC-ND 4.0)
The authors publishing under this license with HRA retain all rights which means that the authors can read, print, and download, redistribute or republish (eg, display in a repository), translate the article (for private use only, not for distribution), download for text and data mining, reuse portions or extracts in other works, but they are not allowed to sell or re-use for commercial purposes or re-use for non-commercial purposes; without asking prior permission from the publisher, provided the original work is properly cited.

Language
HRA accepts publications in English and French . All the publications should have an abstract in both languages. Whenever possible, picture captions and table titles should be in both languages. All accepted manuscripts are copy-edited.
Particularly if English is not your first language, before submitting your manuscript, HRA advises the work to have it edited for language.
Artificial Intelligence (AI)–Assisted Technology
At submission, the authors should disclose whether they used artiﬁcial intelligence (AI)–assisted technologies in the production of the publication and how AI was used. However, authors should not list AI and AI-assisted technologies as an author or co-author, nor cite AI as an author.

TYPES OF ARTICLES
The main sections are original articles, clinical cases, brief reports, review articles, letters to the editor, pictures and disease, medicine and society or book reviews

CHECK LISTS
1. For studies dealing with diagnostic accuracy, use the Standards for Reporting of Diagnostic Accuracy (STARD) http://www.equator-network.org/reporting-guidelines/stard/
2. For randomized controlled trials, use the CONSORT (Consolidated Standards of Reporting Trials) statement (BMJ 2010; 340).
3. For systemic reviews and meta-analyses of diagnostic test accuracy studies, follow the PRISMA-DTA (Preferred Reporting Items for Systematic Reviews-Diagnostic Test Accuracy) guidelines) http://www.prisma-statement.org/Extensions/DTA.
4. For observational studies, such as cohort, case-control, or cross-sectional studies, use the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines. https://www.strobe-statement.org/index.php?id=strobe-home

ARTICLE PROCESSING CHARGES (APC)
Article submission is free of charges, but if your paper is accepted for publication, you will be asked to pay article processing charges to cover publications costs (220-250 $), depending on the type, complexity and length of the work, and on the number of authors. To guarantee HRA's independence, APC cover publication charges such as electronic archiving, plagiarism checking, editing, peer review process, site maintenance and web-hosting, proofreading, quality check, PDF designing and article maintenance.
FAST TRACK
Please, contact the editor-in-chief. Special article processing charges may apply.

About the Journal

Current Issue

Front Cover Page

In This Issue

About Health Research in Africa

Research Articles

Medicine and Surgery in the Tropics

Case Reports

Author Guidelines

Endorsed by

Our Partners

Make a Submission

Follow us on social media

Useful links

Browse

Information

Language

Keywords

EDITORIAL POLICIES

Current Issue

Developed By